J. B. Chemicals & Pharmaceuticals Limited Share Price NSE India S.E.
Equities
JBCHEPHARM
INE572A01036
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,907 INR | +2.23% | +6.64% | +17.36% |
Sales 2024 * | 35.01B 420M 33.48B | Sales 2025 * | 40.58B 486M 38.8B | Capitalization | 289B 3.47B 277B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.6M 5.39B | Net income 2025 * | 7.06B 84.65M 6.75B | EV / Sales 2024 * | 8.3 x |
Net Debt 2024 * | 1.32B 15.8M 1.26B | Net cash position 2025 * | 4.41B 52.9M 4.22B | EV / Sales 2025 * | 7.02 x |
P/E ratio 2024 * |
48.4
x | P/E ratio 2025 * |
38.7
x | Employees | 5,095 |
Yield 2024 * |
0.65% | Yield 2025 * |
0.77% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +2.23% | ||
1 week | +6.64% | ||
Current month | +15.53% | ||
1 month | +12.45% | ||
3 months | +12.49% | ||
6 months | +36.98% | ||
Current year | +17.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 04/10/20 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 30/08/20 | |
Akshay Tanna
BRD | Director/Board Member | 40 | 11-06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 09/02/21 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1,907 | +2.23% | 79 262 |
26/04/24 | 1,865 | +0.12% | 72,657 |
25/04/24 | 1,863 | +2.10% | 191,404 |
24/04/24 | 1,825 | +2.26% | 133,182 |
23/04/24 | 1,784 | -0.21% | 113,740 |
Delayed Quote NSE India S.E., April 29, 2024 at 11:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+26.47% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.72% | 231B | |
+5.26% | 200B | |
-8.88% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- JBCHEPHARM Stock
- JBCHEPHARM Stock